Skip to main content

Figure 2  .

Figure 2  

Diagrammatic representation of the experimental protocol. Animals were treated with levosimendan (levo) orally for 10 days. Thirty minutes before coronary artery ligation (CAL), animals were given a bolus dose of levosimendan intravenously, followed by a continuous infusion throughout coronary artery ligation and reperfusion.